Jiangsu Hengrui | 600276 - Selling And Administration Expenses

Stock Price
56.05
Daily Change
-0.35 -0.62%
Monthly
3.60%
Yearly
11.50%
Q2 Forecast
54.92

Jiangsu Hengrui reported CNY2.81B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Sh Fosun Pharma CNY 4.44B 1.32B Dec/2025
Sh Pharmaceutical CNY 5.03B 372.15M Dec/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Wuxi Apptec CNY 1.04B 261.09M Dec/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025